InvestorLens

NEO — NEOGENOMICS INC

Health Care

Sign in to save4 tracked investors reported this
For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

Why are billionaires buying NEO?

Built from public SEC filings and public economic data. Not a recommendation.

Confidence
95
Institutional Conviction
Strong distribution · 0 buying vs 2 selling last quarter
8
Macro Tailwind
Macro conditions are mixed for this sector
53
Why? — Evidence & Confidence ▾

Of 2 tracked investors who changed their NEO position last quarter, 0 bought and 2 sold (0% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 53/100 in a Overheat regime).

Supporting evidence
  • +4 tracked investors reported holding NEO at their latest filing
Contradicting evidence — always shown
  • −2 tracked investors reduced or exited last quarter (1 reduced, 1 sold out)
  • −13F data is disclosed up to 45 days after quarter end — positions may have changed since
Know the limits
  • · 13F disclosure lag (up to 45 days)
  • · Tracked investors are a sample, not the whole market
  • · Sector regime fit is a historical average, not a guarantee

Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 9/18/2026.

About NEOGENOMICS INC (NEO)

NEOGENOMICS INC (NEO) appears in the most recent 13F filings of 4 tracked institutional investors. NEOGENOMICS INC is classified in the Health Care sector. The largest disclosed position is held by Izzy Englander (Millennium Management), valued at $66M. Across recent filings, tracked investors recorded 5 new positions, 6 increased, 7 reduced, and 4 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in NEO

50
/100
Mixed Activity
Added / Increased11
Reduced7
Exited4
BearishBullish
Crowded Trade Score™

How many top investors track NEO

27
/100
Emerging Interest
4investors

A small number of top investors own this.

UndiscoveredCrowded
151015+

NEO Ownership Composition

How NEOGENOMICS INC is held across tracked investor types, based on reported 13F positions.

Dominant Type
Multi-Strategy / Quant
97% of tracked value
Institutions
4
tracked investors
Total Reported
$47.8M
combined 13F value
Types3
  • Multi-Strategy / Quant97.2%
  • Value & Distressed2.0%
  • Macro0.7%
Multi-Strategy / Quant(2)
97.2%
Value & Distressed(1)
2.0%
Macro(1)
0.7%

Tracked investors currently reporting NEO

2 tracked investors have since exited this position — listed separately below.

  • Izzy EnglanderJun 30, 2026
    Millennium Management
    Shares
    3.1M
    Value
    $44.9M
    % Portfolio
    0.02%
  • Howard MarksJun 30, 2026
    Oaktree Capital Management
    Shares
    1M
    Value
    $979.7K
    % Portfolio
    0.01%
  • Ken GriffinJun 30, 2026
    Citadel Advisors
    Shares
    106.5K
    Value
    $1.6M
    % Portfolio
    0.00%
  • Paul Tudor JonesJun 30, 2026
    Tudor Investment Corp
    Shares
    24K
    Value
    $350.2K
    % Portfolio
    0.00%

Previously held NEO

These investors reported NEO in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.

InvestorFirmLast reported sharesValue thenLast held
Steve CohenPoint72 Asset Management1M$14.3MJun 30, 2024
Ray DalioBridgewater Associates91.2K$676.6KMar 31, 2026

Recent activity

Frequently asked questions

How many institutional investors hold NEO?
4 tracked institutional investors disclosed a position in NEO (NEOGENOMICS INC) in their most recent 13F filing.
Who is the largest institutional holder of NEO?
Izzy Englander, Millennium Management, holds the largest disclosed position in NEO, valued at $66M.
Did institutional ownership of NEO increase or decrease?
Across recent 13F filings, tracked investors recorded 5 new positions, 6 increased, 7 reduced, and 4 fully exited NEO.
What sector is NEO in?
NEOGENOMICS INC is classified in the Health Care GICS sector.
Where does this NEO ownership data come from?
SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.